CHÉOS investigators are at the forefront of health outcomes research, including health economics, pharmacoeconomics and patient-reported outcomes. Their work evaluates the effectiveness of health interventions in populations to inform policies, transforming health systems at the local, national and international levels in the future.
CHÉOS Scientist Dr. Brian Grunau says results from the first peer-reviewed study in North America on COVID-19 mRNA vaccines could inform vaccination policies
Read More
While people understood public health guidelines, they did not adhere to them, citing need for food, medication & fresh air
Read More
Study highlights the importance of opioid agonist therapy during the overdose crisis, including the need to support continued treatment
Read More
CHÉOS Health Economists publish Canada-focused research to guide policy decisions and health care spending
Read More
Dr. Andrew Kestler is involved in a new study interviewing people with opioid use disorder to understand their perspectives of the pandemic
Read More
This World Hepatitis Day we take a look at some of the most recent research to result from the BC Hepatitis Testers Cohort
Read More